Australian government grant to support needle-free vaccine technology

Vaxxas will receive an $8.2 million second-round grant as part of the Australian Federal Government’s Modern Manufacturing Initiative (MMI) to support manufacturing scale-up in its Australian manufacturing facility.    The funding will support the specialised infrastructure necessary to manufacture its high-density microarray patch (HD-MAP) device at its state-of-the-art biomedical facility currently under construction at Northshore, […]